NCT03021499: A trial that was reported late by Aurinia Pharmaceuticals Inc.
This trial has reported, although it was 154 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03021499 |
|---|---|
| Title | A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 17, 2017 |
| Completion date | Sept. 24, 2019 |
| Required reporting date | Sept. 23, 2020, midnight |
| Actual reporting date | Feb. 25, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 154 |